PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Public Health Research, Medical School, Nanjing University, Nanjing, China.\', \'Department of Antibody, Abrev Biotechnology Co., Ltd., Nanjing, China.\', \'Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, School of Life Sciences, Tianjin University, Tianjin, China.\', \'Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People\'s Hospital, Shenzhen, China.\', \'State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.\', \'Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.\', \'School of Life Sciences, Ningxia University, Yinchuan, China.\', \'Department of Antibody, Y-clone Medical Science Co. Ltd., Suzhou, China.\', \'Institute for Infection and Immunity, St. George\'s University of London, London, United Kingdom.\', \'Life Sciences Institute, Zhejiang University, Zhejiang, China.\', \'Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China.\', \'State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2022.865401
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35371009
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22).
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all